Bill Gates giving $50 million for Alzheimer's research

November 13, 2017

Microsoft co-founder Bill Gates announced Monday that he is investing $50 million to fund research into treatment for Alzheimer's disease.

Gates, in an entry on his blog, said he was making the investment from his personal fortune and not with his charitable Bill & Melinda Gates Foundation.

"Of all the disorders that plague us late in life, one stands out as a particularly big threat to society: Alzheimer's disease," Gates said.

"Scientists have yet to figure out what exactly causes Alzheimer's or how to stop the disease from destroying the brain," he said. "In the United States, it is the only cause of death in the top 10 without any meaningful treatments."

Gates said he was investing $50 million in the London-based Dementia Discovery Fund, a private-public venture that supports innovative research into dementia.

The multi-billionaire philanthropist said finding for Alzheimer's, which affects nearly 50 million people worldwide, was particularly urgent since improved medical care meant people were living longer.

He noted that his own father would soon celebrate his 92nd birthday—"a milestone that was practically unimaginable when he was born."

Gates said there is a nearly 50 percent chance of developing Alzheimer's for people who live into their mid-80s.

"If you get the in your 60s or 70s, you might require expensive care for decades," he said.

"Absent a major breakthrough, expenditures will continue to squeeze healthcare budgets in the years and decades to come," Gates said.

Gates acknowledged that making progress against Alzheimer's would be a long-term project.

"The first Alzheimer's treatments might not come to fruition for another decade or more, and they will be very expensive at first," he said.

"Once that day comes, our foundation might look at how we can expand access in ," he said.

But Gates said he was optimistic.

"We've seen scientific innovation turn once-guaranteed killers like HIV into chronic illnesses that can be held in check with medication," he said. "I believe we can do the same (or better) with Alzheimer's."

The Bill & Melinda Gates Foundation has concentrated mainly on fighting communicable diseases such as malaria and polio in poor countries.

Explore further: Bill Gates hopeful of AIDS vaccine in 10 years

Related Stories

Bill Gates hopeful of AIDS vaccine in 10 years

June 26, 2015
Billionaire and philanthropist Bill Gates, who spends millions of dollars on AIDS drug development, said Friday he hoped for a vaccine against the disease within the next decade as a cure remains far off.

Recommended for you

What really causes Alzheimer's and how might we fix it?

May 23, 2018
There have been a lot of theories about what causes Alzheimer's disease. Many of them have given rise to experimental treatments of one form or another. None of them have worked much better than taking anything you might ...

Study predicts most people with earliest Alzheimer's signs won't develop dementia associated with the disease

May 22, 2018
During the past decade, researchers have identified new ways to detect the earliest biological signs of Alzheimer's disease. These early signs, which are detected by biomarkers, may be present before a person starts to exhibit ...

Moderate to high intensity exercise does not slow cognitive decline in people with dementia

May 16, 2018
Moderate to high intensity exercise does not slow cognitive (mental) impairment in older people with dementia, finds a trial published by The BMJ today.

Mutation discovered to protect against Alzheimer's disease in mice

May 16, 2018
Researchers at the RIKEN Center for Brain Science have discovered a mutation that can protect against Alzheimer's disease in mice. Published in the scientific journal Nature Communications, the study found that a specific ...

Most deprived are nearly twice as likely to develop dementia

May 16, 2018
Older adults in England with fewer financial resources are more likely to develop dementia, according to new UCL research.

Scientists discover a variation of the genome predisposing to Alzheimer's disease

May 15, 2018
An article published in Nature Medicine shows that the inheritance of small changes in DNA alters the expression of the PM20D1 gene and is associated with an increased risk of developing Alzheimer's disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.